Your session is about to expire
← Back to Search
MDMA for PTSD
Study Summary
This trial will study how MDMA affects the brain of people with PTSD, in hopes of finding a better way to treat the disorder.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 1 & 2 trial • 12 Patients • NCT02876172Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I don't have any health issues or take medications that make MDMA unsafe for me.My BMI is over 30 or I weigh more than 250 pounds.I have stopped taking anxiety, antipsychotic, and SRI meds for the required time.My doctor found something unusual during my physical exam.I have never used MDMA.I do not have any major illnesses found through physical exams or tests.My blood pressure is usually above 140/90 mmHg.I have never used MDMA.I am between 21-55 years old, not pregnant, and use or agree to use non-hormonal birth control or am unable to have children.My family has a history of heart diseases.You have a score of 23 or higher on the CAPS-5 at screening.You are able to read and write English as a primary language.I have been diagnosed with PTSD by a professional.I am not using hormonal contraceptives.I agree to have someone drive me home after the sessions.I have not been diagnosed with bipolar, schizophrenia, or schizoaffective disorder.I have had a mild traumatic brain injury.I agree to have someone drive me home after the sessions.I don't have health issues or take medications that make MDMA unsafe for me.I have a history of serious medical or neurological conditions.I am not pregnant, breastfeeding, nor have I tested positive for pregnancy recently.I am not taking any medications listed for the study.I am between 21 and 55 years old.You are able to provide written informed consent according to Yale HIC guidelines.I have fainted before or my usual blood pressure is below 100.I have been diagnosed with PTSD by a professional.I am not taking any of the medications listed for the study.
- Group 1: MDMA
- Group 2: Niacin
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experimental study open to geriatric patients?
"For admittance into this clinical trial, the age range must be between 21 and 55. There are 46 studies aimed at those younger than 18 years old, while 345 studies target those over 65."
Are there any past experiments that looked into the therapeutic advantages of MDMA?
"Presently, there are 19 separate clinical trials for the use of MDMA. One is currently in Phase 3 and 35 locations across the country have studies running. The highest concentration of these tests can be found in Knoxville, TN."
Has the FDA sanctioned MDMA for medicinal use?
"Our Power team gauged MDMA's safety at a 1, as this is an early Phase 1 trial which only has scant evidence of its effectiveness and security."
What has been the traditional application of MDMA?
"MDMA is often used to reduce the risk of cardiovascular illness. It also may be effective for managing dyslipidemias, pancreatitis and lipidemia."
How many applicants are being considered for participation in this research endeavor?
"Affirmative, clinicaltrials.gov indicates that this trial is presently recruiting participants. It was originally posted on January 15th 2023 and most recently updated on October 20th 2022, aiming to secure participation from 20 individuals at a single medical centre."
Are there still places available to be a participant in this experiment?
"Based on the clinicaltrials.gov listing, this clinical trial is actively recruiting participants. It initially appeared online on January 15th 2023 and was last updated October 20th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger